Gibco Adherent Kidney Media Panel : A Media Panel Solution

Discover the power of the Gibco Adherent Kidney Media Panel for rapidly identifying serum-free growth and productivity media, revolutionizing your viral vaccine production. Our panel offers a comprehensive evaluation of media candidates, providing options that support improved cell growth and enhanced productivity. With proven results of up to 3.4-fold improved cell growth and up to 10.6-fold enhanced productivity, this innovative solution is designed to meet the evolving needs of the viral vaccine industry.

The Adherent Kidney Media Panel is your gateway to diverse, ready-to-use liquid formulations, protocols, and expert support, ensuring the rapid identification of animal origin-free and serum-free media candidates for adherent virus production. Whether you are working with Vero, MDCK, or BHK-21 cells, our panel formulations can support comparable or stronger cell growth relative to other commercially available media.

Our application note offers valuable insights into the advantages of utilizing mammalian cell culture-based production processes for viral vaccines, the role of adherent cell lines like Vero in boosting productivity, and the challenges and solutions associated with eliminating serum and transitioning to AOF media and supplements in the viral vaccine industry.